| IBM |
Report |
Total Revenue (Q2 2026) |
MISS |
pred ~$17.20B vs. cons $17.83B |
HIGH |
| IBM |
Report |
Op EPS (Q2 2026) |
MISS |
pred ~$2.93 vs. cons $2.976 |
HIGH |
| IBM |
Report |
Software Revenue (Q2 2026) |
MISS |
pred ~$7.76B vs. cons $8.20B |
HIGH |
| IBM |
Guide |
FY 2026 Revenue (FY26) |
LOWER |
guide ~$69.6-70.2B vs. cons $71.45B |
HIGH |
| IBM |
Guide |
FY 2026 FCF (FY26) |
LOWER |
guide ~$14.5-15.0B vs. cons $15.85B |
MEDIUM |
| IBM |
Guide |
Software Growth FY26 |
LOWER |
guide ~7-8% vs. cons ~10% |
HIGH |
| IBM |
Guide |
Op PTI Margin Expansion FY26 |
UNCHANGED |
guide ~1pt vs. cons ~1pt |
MEDIUM |
| IBM |
Guide |
Consulting Trajectory FY26 |
UNCHANGED |
guide low-to-mid SD maintained vs. cons |
MEDIUM |
| IBM |
Return |
Day-1 residual (stock − beta × S&P 500) |
-5.0% |
— |
MEDIUM |
| IBM |
Return |
5-day cumulative residual |
-7.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — sell-side estimate cuts pull stock lower as FY models reprice; no catalyst to reverse until H2 data |
MEDIUM |